Vorträge

2017

13.–17.08.2017 Metallomics 2017, Vienna, Austria

Christopher Gerner “On the molecular mechanism of action of organometallic anticancer drugs”


03.-06.04.2017 ANAKON 2017, Tübingen, Germany

Christopher Gerner, Ammar Tahir, Rupert L. Mayer, Marie Lisa Boehm, Andrea Bileck, Besnik Muqaku, Albrecht Reichle, Astrid Slany “Combinatory shotgun proteomics and shotgun eicosadomics study of platelets activated by calcium mobilization”


10.-12.04.2017 6th European Lipidomic Meeting ELM 2017, Toulouse, France

Christopher Gerner “The amazing functional plasticity of platelets investigated by combining proteomics with lipidomics”

Laura Niederstaetter “Combined Proteome and Eicosanoid Profiling Approach for Revealing Implications of Human Fibroblasts in Chronic Inflammation”


12.-14.01.2017 ÖGDV 2017 Science Days, Fuschl am See, Austria

Christopher Gerner “Combined proteomics and lipidomics supports the investigation and discovery of novel pathomechanisms”

2016

13.-15.11.2016 2nd Lipidomics Forum, ISAS, Dortmund, Germany

Christopher Gerner “Dexamethasone fails to inhibit the secretion of several inflammatory chemokines and counteracts the formation of both pro- and anti-inflammatory eicosanoids in human fibroblasts”


14.-15.11.2016 Global Engage’s Mass Spectrometry & Proteomics Congress, London, UK

Christopher Gerner “From novel disease mechanisms to predictive biomarkers: combining proteomics and lipidomics for the investigation of metastatic melanoma”


04.-05.11.2016 25. Jahrestagung der Austrian Breast & Colorectal Cancer Study Group, Saalfelden, Austria

Christopher Gerner “Comprehension of cancer disease mechanisms by the combination of proteomics, lipidomics and metabolomics”


14.10.2016 Department of Analytical Chemistry – RCPTM, Palacky University, Olomouc, Czech Republic, seminar lecture invited by Prof. Karel Lemr

Christopher Gerner “Relating eicosanoid formation with cytokine secretion offers new insight into the regulation of inflammatory processes”


12.-15.09.2016 The 3rd Annual European Congress of The Association for Mass Spectrometry: Applications to the Clinical Lab MSACL 2016 EU, Salzburg, Austria

Christopher Gerner “Metabolomics of Fingersweat: Individual Assessment of  Metabolic Parameters based on Fingerprint Analyses”


22.--25.06.2016 X Annual Congress of the European Proteomics Association, Istanbul, Turkey

Besnik Muqaku, Martin Eisinger, Samuel Meier, Astrid Slany, Albrecht Reichle, Christopher Gerner: “Systemic rather than tumor specific energy expenditure processes are responsible for human melanoma-associated cachexia”


09.-11.06.2016 13th Pneumology Update 2016, 13th PneumoUpdate, Igls, Austria, plenary lecture

Christopher Gerner “Metabolomics und Lipidomics beim NSCLC”


10.05.2016 Experimentalvortrag im Zuge der Ausstellung “Die Schönheit der Elemente” im Österreichischen Gesellschafts- und Wirtschaftsmuseum

Christopher Gerner, Peter Unfried “Was ist das? – Alte und neue Methoden der Analytik”


08.-10.05.2016 Time and Light: Novel Concepts and Models in Sensory and Chronobiology, Vienna, Austria

Samuel M. Meier, Clemens Langbauer, Florian Raible, Christopher Gerner “Reproducible Quantification of Metabolites from Fingertips via Triple-Quadrupole Mass Spectrometry”


31.03./01.04.2016 acib Workshop on Analytical Chemistry 2016, Vienna, invited by Assoc. Prof. Stephan Hann

Astrid Slany, Andrea Bileck, Dominique Kreutz, Rupert L. Mayer, Besnik Muqaku, Christopher Gerner “Contribution of human fibroblasts and endothelial cells to the Hallmarks of Inflammation as determined by proteome profiling”


07./08.03.2016 1st International Meeting on Reprogramming Cancer Cells via Anakoinosis as a Novel Anticancer Approach: Facts, Expectations and Open Questions, Rome, Italy

Christopher Gerner “Tumor-stroma interactions investigated by proteomics and metabolomics”


23./24.02.2016 27th MassSpec Forum Vienna 2016, Vienna

Ammar Tahir: “Implementation of an orbitrap based eicosanoids analysis platform for the identification of cell type specific inflammation signature”

Astrid Slany, Andrea Bileck, Dominique Kreutz, Rupert L. Mayer, Besnik Muqaku, Christopher Gerner: “Contribution of human fibroblasts and endothelial cells to the Hallmarks of Inflammation as determined by proteome profiling”

Besnik Muqaku, Martin Eisinger, Samuel Meier, Astrid Slany, Albrecht Reichle, Christopher Gerner: “Systemic rather than tumor specific energy expenditure processes are responsible for human melanoma-associated cachexia”


09./10.02.2016 33. Forum Analytik, Vienna

Denise Wolrab, Peter Frühauf, Christopher Gerner: “Die Trennnung von polaren Analyten mittels SFC – Evaluierung von stationären Phasen, Modifier und Additiven”

Christopher Gerner, Besnik Muqaku, Andrea Bileck: “Modulation von Entzündungsprozessen durch Kaffeekonsum: Erfassung individualisierter Zytokin- und Eicosanoid-Signaturen mittels gezielter massenspektrometrischer Analysen”

2015

20.11.2015 Montanuniversität Leoben, Department of General, Analytical and Physical Chemistry, Leoben, Austria, seminar lecture invited by Prof. Wolfhard Wegscheider

Christopher Gerner: “Can we improve the accuracy of measurements of small molecules in biological samples using multi-omics approaches?”


17.11.2015 Gesellschaft der Ärzte in Wien – State of the Art: Proteomics und ihre Bedeutung für die Klinik, Wien, eingeladen von der Gesellschaft der Ärzte in Wien

Astrid Slany: “New insights into tumor biology and drug effects in multiple myeloma obtained by proteome profiling”

Rupert Mayer: “Ultra-Deep mass spectrometry-based proteomics enables new insights into chronic lymphocytic leukemia”


26./27.10.2015 1st International Course Workshop “Biomolecular Recognition and Mass Spectrometry” BRMS-1 2015, Rüsselsheim, Germany

Christopher Gerner: “Assessment of the efficiency of antibody-based protein depletion for serum proteome profiling for the investigation of cancer-associated cachexia”


30.9.2015 University Hospital Regensburg, Regensburg, Germany, seminar lecture invited by Prof. Albrecht Reichle

Christopher Gerner: “Proteome analyses of serum of patients with metastatic melanoma”


21.-24.9.2015 16th Austrian Chemistry Days, Joint Meeting of the Italian & Austrian Chemical Societies, Innsbruck, Austria

Dominique Kreutz, Andrea Bileck, Samuel M. Meier, Bernhard Keppler, Christopher Gerner: “Investigation of novel metal-based anticancer drug candidates’ mechanisms of action by in-depth proteome profiling”


26.-28.8.2015 13th Austrian Proteomic Research Symposium and Late Summer Meeting 2015, APRS2015, Klosterneuburg, Austria

Dominique Kreutz, Andrea Bileck, Astrid Slany, Walter Jäger, Christopher Gerner: “Proteome profiling for evaluation of drug effects – a pilot study using a resveratrol derivative”


20./22.7.2015 British Society for Proteome Research 2015 Meeting, United Kingdom, Reading 2015

Christopher Gerner, Andrea Bileck, Dominique Kreutz, Besnik Muqaku, Rupert Mayer, Astrid Slany: “Proteome signatures of inflammatory primary human mesenchymal cells”

Andrea Bileck, Astrid Slany, Dominique Kreutz, Christopher Gerner: “Evaluation of signalling pathways in primary human peripheral blood mononuclear cells by in-depth proteome profiling”  


12./13.6.2015 11th ASAC JunganalytikerInnenforum, Innsbruck 2015

Andrea Bileck, Dominique Kreutz, Astrid Slany, Christopher Gerner: “Comprehensive LC-MS/MS analyses enables assessment of signalling pathways in human blood cells”

Dominique Kreutz, Andrea Bileck, Walter Jäger, Christopher Gerner: “Assessment of drug induced proteome alterations exemplified on four breast cancer cell lines treated with the resveratrol derivative 3,3’,4,4’,5,5’-hexahydroxystilbene”

Rupert Mayer, Samuel Meier, Clemens Langbauer, Christopher Gerner: “Reproducible Quantification of Metabolites from Fingertips via Triple-Quadrupole Mass Spectrometry”


17./18.04.2015 23. Jahrestagung der Biomedizinischen AnalytikerInnen, Graz

Andrea Bileck: “Proteom-Analysen zeigen unerwartete Effekte von Dexamethason in primären humanen mononukleären Zellen des peripheren Blutes


17./18.02.2015 26th Mass Spectrometric Discussion-Meeting MassSpec-Forum-Vienna 2015, Vienna

Ammar Tahir, Astrid Slany, Christopher Gerner: “Development of an automated search engine for the LC/MS profiling of eicosanoids


15.1.2015 University of Vienna, Department of Analytical Chemistry, seminar lecture invited by Prof. Gunda Köllensperger

Astrid Slany: “Proteomics in cancer research


2014

20.11.2014 University of Vienna, Department of Analytical Chemistry, seminar lecture invited by Prof. Gunda Köllensperger

Samuel Meier: “Mass spectrometry based assays in preclinical metallodrug research


23./24.09.2014 12th Austrian Proteomic Research Symposium APRS 2014, Salzburg

Besnik Muqaku, Andrea Bileck, Dominique Kreutz, Rupert Mayer, Astrid Slany, Christopher Gerner: "MRM-based quantitative secretome analysis of inflammatory activated primary human cells"

Andrea Bileck, Astrid Slany, Michael Groessl, Dominique Kreutz, Kerstin Gloessmann, Georg Pfeiler and Christopher Gerner: "Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblast"

Christopher Gerner, Tamara Weiss, Andrea Bileck, Astrid Slany, Dominique Kreutz, Sabine Taschner-Mandl, Ingeborg M. Ambros, and Peter F. Ambros: "Schwannomics: Profiling Schwann cells as potential prototype for tumor-inhibiting stromal cell"


17.09.2014 30th International Symposium on Chromatography ISC 2014, Salzburg

Christopher Gerner, Besnik Muqaku, Andrea Bileck, Ammar Tahir, Dominique Kreutz, Rupert Mayer, Astrid Slany: "Cell type-specific secretome profiles obtained from inflammatory stimulated primary human cells can be used for drug evaluation"


05.09.2014 The 1st Annual MSACL EU Conference MSACL 2014 EU, Salzburg

Christopher Gerner, Besnik Muqaku, Andrea Bileck, Dominique Kreutz, Rupert Mayer, Astrid Slany: "Inflammatory cytokine and chemokine profiles of primary human cells determined with Chip-HPLC – triple quadrupole mass spectrometry"


02.07.2014 Central and Eastern European Proteomics Conference (CEEPC)

Astrid Slany: “Comparative proteome profiling and targeted proteomics-based drug evaluation


29.04.2014 1st Vienna Metabolism Club

Gunda Köllensperger, Christopher Gerner: “The Mass Spectrometry Center: A Multi-Purpose Service Center, Integrating Proteomics and Metabolomics for Biomedical Research”  


02.04.2014 St. Anna Kinderkrebsforschung, Wien
Seminarvortrag eingeladen von Prof. Dr. Peter Ambros

Tamara Weiss, Christopher Gerner: „Schwann cells: shedding new light on old players in tumor biology”  


19.02.2014 MassSpec-Forum Vienna 2014

Astrid Slany, Samuel Meier, Christopher Gerner: „HRMS and MRM based quantitative secretome analysis – a key for assessing cell functions and drug effects


05.02.2014, Regensburg, Deutschland
Klinikum der Universität Regensburg Seminarvortrag eingeladen von Prof. Dr. Albrecht Reichle

Christopher Gerner: „Evaluation of tumor-suppressive and tumor-promoting stroma cell activities by proteome profiling focussing on secretome analyses